MKI67 and breast carcinoma: Chen et al. [26] suggested that high ki-67 is a predictor of pathologic complete response (pCR) in breast cancer patients undergoing neoadjuvant therapy; Yoshikawa et al. [27] suggested that ki-67 could be an effective biomarker for preoperative radiotherapy in rectal cancer.